There were 1,543 press releases posted in the last 24 hours and 413,217 in the last 365 days.

Research Report Identifies Control4, Nevro, American Equity Investment Life Holding, Xperi, Spirit Aerosystems, and Medidata Solutions with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

NEW YORK, Nov. 22, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Control4 Corporation (NASDAQ:CTRL), Nevro Corp. (NYSE:NVRO), American Equity Investment Life Holding Company (NYSE:AEL), Xperi Corporation (NASDAQ:XPER), Spirit Aerosystems Holdings, Inc. (NYSE:SPR), and Medidata Solutions, Inc. (NASDAQ:MDSO), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

CTRL DOWNLOAD: http://Fundamental-Markets.com/register/?so=CTRL
NVRO DOWNLOAD:
http://Fundamental-Markets.com/register/?so=NVRO
AEL DOWNLOAD:
http://Fundamental-Markets.com/register/?so=AEL
XPER DOWNLOAD:
http://Fundamental-Markets.com/register/?so=XPER
SPR DOWNLOAD:
http://Fundamental-Markets.com/register/?so=SPR
MDSO DOWNLOAD:
http://Fundamental-Markets.com/register/?so=MDSO

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Control4 Corporation (NASDAQ:CTRL), Nevro Corp. (NYSE:NVRO), American Equity Investment Life Holding Company (NYSE:AEL), Xperi Corporation (NASDAQ:XPER), Spirit Aerosystems Holdings, Inc. (NYSE:SPR), and Medidata Solutions, Inc. (NASDAQ:MDSO) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. All information in this release was accessed November 21st, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (except per share amounts).

-----------------------------------------

CONTROL4 CORPORATION (CTRL) REPORT OVERVIEW

Control4's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Control4 reported revenue of $64.74 vs $55.19 (up 17.32%) and diluted earnings per share $0.19 vs $0.07 (up 171.43%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Control4 reported revenue of $208.80 vs $163.18 (up 27.96%) and diluted earnings per share $0.53 vs -$0.07. Control4 is expected to report earnings on February 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.21. The estimated EPS forecast for the next fiscal year is $0.81 and is expected to report on February 8th, 2018.

To read the full Control4 Corporation (CTRL) report, download it here: http://Fundamental-Markets.com/register/?so=CTRL

-----------------------------------------

NEVRO CORP. (NVRO)  REPORT OVERVIEW

Nevro's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Nevro reported revenue of $82.26 vs $60.92 (up 35.02%) and diluted earnings per share -$0.21 vs -$0.14. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Nevro reported revenue of $228.50 vs $69.61 (up 228.28%) and diluted earnings per share -$1.12 vs -$2.54. Nevro is expected to report earnings on February 22nd, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.34. The estimated EPS forecast for the next fiscal year is -$0.42 and is expected to report on February 22nd, 2018.

To read the full Nevro Corp. (NVRO) report, download it here: http://Fundamental-Markets.com/register/?so=NVRO

-----------------------------------------

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY (AEL) REPORT OVERVIEW

American Equity Investment Life Holding's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, American Equity Investment Life Holding reported revenue of $905.95 vs $630.06 (up 43.79%) and diluted earnings per share $0.63 vs -$0.09. For the twelve months ended December 31st, 2016 vs December 31st, 2015, American Equity Investment Life Holding reported revenue of $2,220.28 vs $1,518.94 (up 46.17%) and diluted earnings per share $0.97 vs $2.72 (down 64.34%). American Equity Investment Life Holding is expected to report earnings on February 14th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.63. The estimated EPS forecast for the next fiscal year is $2.71 and is expected to report on February 14th, 2018.

To read the full American Equity Investment Life Holding Company (AEL) report, download it here: http://Fundamental-Markets.com/register/?so=AEL

-----------------------------------------

XPERI CORPORATION (XPER) REPORT OVERVIEW

Xperi Corporation's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Xperi Corporation reported revenue of $88.51 vs $62.43 (up 41.76%) and diluted earnings per share -$0.24 vs $0.48. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Xperi Corporation reported revenue of $259.57 vs $273.30 (down 5.03%) and diluted earnings per share $1.12 vs $2.23 (down 49.78%). Xperi Corporation is expected to report earnings on February 28th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.32. The estimated EPS forecast for the next fiscal year is $2.69 and is expected to report on February 28th, 2018.

To read the full Xperi Corporation (XPER) report, download it here: http://Fundamental-Markets.com/register/?so=XPER

-----------------------------------------

SPIRIT AEROSYSTEMS HOLDINGS, INC. (SPR) REPORT OVERVIEW

Spirit Aerosystems' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Spirit Aerosystems reported revenue of $1,748.20 vs $1,711.40 (up 2.15%) and diluted earnings per share $1.26 vs $1.16 (up 8.62%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Spirit Aerosystems reported revenue of $6,792.90 vs $6,643.90 (up 2.24%) and diluted earnings per share $3.70 vs $5.66 (down 34.63%). Spirit Aerosystems is expected to report earnings on February 7th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.89. The estimated EPS forecast for the next fiscal year is $5.47 and is expected to report on February 7th, 2018.

To read the full Spirit Aerosystems Holdings, Inc. (SPR) report, download it here: http://Fundamental-Markets.com/register/?so=SPR

-----------------------------------------

MEDIDATA SOLUTIONS, INC. (MDSO) REPORT OVERVIEW

Medidata Solutions' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Medidata Solutions reported revenue of $140.08 vs $120.06 (up 16.67%) and diluted earnings per share $0.21 vs $0.13 (up 61.54%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Medidata Solutions reported revenue of $463.38 vs $392.51 (up 18.06%) and diluted earnings per share $0.51 vs $0.23 (up 121.74%). Medidata Solutions is expected to report earnings on February 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.23. The estimated EPS forecast for the next fiscal year is $0.92 and is expected to report on February 8th, 2018.

To read the full Medidata Solutions, Inc. (MDSO) report, download it here: http://Fundamental-Markets.com/register/?so=MDSO

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@fundamental-markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.


Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: andrew.duffie@fundamental-markets.com


2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@fundamental-markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.